T. Kikuchi et al.
values of 10b and 11b (J’sphere ODS-H80 column; mobile phase of MeCN/
AcONH4 buffer= 15:85; flow rate of 1 mL/min) were 6.7 and 6.3min,
respectively, whereas the tR value of iodomethane with the same
conditions was 12.5min. The tR values of 12b–14b (J’sphere ODS-H80
column; mobile phase of MeCN/AcONH4 buffer= 30:70; flow rate of
1.5mL/min) were 7.4 (12b), 17.7 (13b), and 16.0min (14b), respectively,
whereas that of iodomethane under these conditions was 8.4min. The
radiochromatograms of the materials were monitored until the
radioactivity in the columns could no longer be detected using a Geiger–
Müller counter (TGS-146B, Hitachi Aloka Medical, Ltd., Tokyo, Japan).
Synthesis of N-(1-ethylpyrrolidin-2-ylmethyl)-hydroxybenzamide
(10a and 11a, precursors for 10b and 11b)
A solution of 3- or 4-benzyloxybenzoyl chloride (1.74 mmol) in dioxane
(15 mL) was added to a stirred solution of K2CO3 (2.89 mmol) and 2-
aminomethyl-1-ethylpyrrolidine (1.56 mmol) in dioxane (15 mL), and the
resulting mixture was stirred for 3 h at ambient temperature. EtOAc
was then added to the reaction, resulting in the formation of a biphasic
solution. The organic phase was collected and washed sequentially with
saturated NaHCO3 and water before being dried over anhydrous MgSO4.
The solvent was then removed in vacuo, and the resulting residue was
purified by column chromatography over Chromatorex NH silica gel (Fuji
Silysia Chemical Ltd., Aichi, Japan) using hexane/EtOAc (2:1, v/v) as the
eluent to give the desired product N-(1-ethylpyrrolidin-2-ylmethyl)-
benzyloxybenzamide (>90%). The benzyl group was removed according
to the following procedure. Triethylsilane (15 mmol) was added to a
mixture of 10% Pd/C (100 mg) and N-(1-ethylpyrrolidin-2-ylmethyl)-
benzyloxybenzamide (1.5mmol) in ethanol (100 mL), and the resulting
mixture was stirred for 3h at ambient temperature. The reaction mixture
was then filtered to remove the Pd/C, and the filtrate was concentrated
under vacuum to give the crude product as a residue, which was purified
by column chromatography over silica gel (Wakogel C-200, Wako Pure
Chemical Ltd.) using EtOAc/2-propanol/28% aqueous NH3 (3:1:0.5, v/v/v)
as the eluent to give the desired product N-(1-ethylpyrrolidin-2-
Production of iodo[11C]methane (1)
[
11C]Carbon dioxide was produced by the 14N(p,α)11C nuclear reaction in
an atmosphere of nitrogen gas containing 0.01% oxygen with 18-MeV
protons using the CYPRIS HM-18 cyclotron (Sumitomo Heavy Industry,
Tokyo, Japan). Following the bombardment process, the [11C]carbon
dioxide was transferred to a reaction vessel containing a 0.05-M solution
of LAH in THF (500 μL) at 0 °C. The THF solvent was then evaporated, and
an aqueous 57% HI solution (400 μL) was added to the vessel. The
resulting mixture was then heated to 150 °C to produce 1. Gaseous 1
was transferred by a N2 gas stream with a flow rate of 30 mL/min and
collected in DMSO or DMF (0.5–1 mL) in a glass vessel at ambient
temperature. The preparation time of 1 was around 7 min following the
end of the bombardment process.
General condition for 11C-methylation
ylmethyl)-hydroxybenzamide (>86%).
N-(1-Ethylpyrrolidin-2-ylmethyl)-3-hydroxybenzamide (10a): 1H-NMR
(300 MHz, CDCl3) δ (ppm): 1.21 (3H, t), 1.71–1.95 (4H, m), 2.27–2.42
(2H, m), 2.72–2.82 (1H, broad m), 2.98–3.05 (1H, m), 3.32–3.43 (2H, m),
3.95–4.04 (1H, m), 6.82–6.85 (1H, dd), 7.25–7.30 (1H, m), 7.45 (1H, d),
7.57 (1H, m) and 7.68 (1H, broad d); 13C-NMR (75 MHz, CDCl3) δ (ppm):
13.04, 22.37, 26.52, 39.25, 48.61, 53.53, 64.23, 114.33, 118.06, 119.21,
129.69, 135.91, 156.60 and 167.70. HRMS (m/z) calcd for C14H20N2O2
[M + H]+: 249.1603; Found: 249.1569.
The DMSO was used as the reaction solvent for the 11C-methylation
reactions using TBAF, whereas DMF was used for the 11C-methylation
reactions using NaH. TBAF (1 eq, 1.0 M in THF, stored in plastic bottle)
or NaH (dispersion in paraffin liquid, 5 eq, 1.0 M in DMF) was added to
a solution of the precursor (1 μmol in 200 μL) 30 or 5 min prior to the
addition of 1, respectively. A DMSO or DMF solution of 1 (~111 MBq,
100 μL) was then added to the reaction mixture, and the resulting
mixture was held at ambient temperature or 80 °C for 3 min. At the end
of reaction, the reaction mixture was cooled on ice and quenched by
the addition of 200 μL of the AcONH4 buffer solution (pH 4.3, 200 mM).
The resulting mixture was then analyzed by HPLC.
N-(1-Ethylpyrrolidin-2-ylmethyl)-4-hydroxybenzamide (11a): 1H-NMR
(300 MHz, CDCl3) δ (ppm): 1.15 (3H, t), 1.66–1.81 (3H, m), 1.88–1.95 (1H, m),
2.26–2.39 (2H, m), 2.79–2.81 (1H, m), 2.86–2.95 (1H, m), 3.23–3.27 (1H, m),
3.36–3.40 (1H, m), 3.74–3.83 (1H, m), 6.84 (2H, d) 7.26 (1H, broad,
overlapped with CDCl3) and 7.72 (2H, d); 13C-NMR (75 MHz, CDCl3) δ
(ppm): 13.32, 22.78, 27.55, 40.33, 48.57, 53.51, 63.43, 115.83, 125.16,
129.07, 160.61 and 168.03. HRMS (m/z) calcd for C14H20N2O2 [M + H]+:
249.1603; Found: 249.1557.
Synthesis of methyl 2-benzamido-2-methylpropanoate (5a,
precursors for 5b) and methyl 2-methyl-2-(N-methylbenzamido)
propanoate (5c)
A solution of benzoyl chloride (2.13 mmol) in dioxane (20 mL) was added
to a stirred solution of K2CO3 (5.86 mmol) and methyl 2-amino-2-
methylpropanoate hydrochloride (1.95 mmol) in water (15 mL), and the
resulting mixture was stirred for 1 h at ambient temperature. EtOAc
was then added to the reaction resulting in the formation of a biphasic
Synthesis of the N-(1-ethylpyrrolidin-2-ylmethyl)-methoxybenzamides
(10c and 11c, analogs of raclopride)
mixture. The organic phase was collected and washed sequentially with The N-(1-ethylpyrrolidin-2-ylmethyl)-methoxybenzamides were prepared
saturated NaHCO3 and water. The organic layer was dried over from the corresponding 3- and 4-methoxybenzoyl chlorides using the
anhydrous MgSO4, and the solvent was removed in vacuo to give a crude procedure described earlier (95%).
product as a residue, which was purified by column chromatography
over silica gel (Wakogel C-200, Wako Pure Chemical Ltd.) using hexane/ (300MHz, CDCl3) δ (ppm): 1.12 (3H, t), 1.63–1.77 (3H, m), 1.86–1.95 (1H, m),
N-(1-Ethylpyrrolidin-2-ylmethyl)-3-methoxybenzamide (10c): 1H-NMR
EtOAc (3:2, v/v) as the eluent to give 5a (88%).
2.15–2.29 (2H, m), 2.67 (1H, broad m), 2.81–2.87 (1H, m), 3.17–3.33 (2H, m),
Methyl 2-benzamido-2-methylpropanoate (5a): 1H-NMR (300 MHz, 3.66–3.74 (1H, m), 3.85 (3H, s), 6.85 (1H, broad s), 7.01–7.05 (1H, m) and
CDCl3) δ (ppm): 1.69 (6H, s), 3.79 (3H, s), 6.79 (1H, broad s), 7.40–7.50 7.27–7.39 (3H, m); 13C-NMR (75 MHz, CDCl3) δ (ppm): 14.06, 22.93, 28.19,
(3H, m) and 7.77–7.80 (2H, m); 13C-NMR (75 MHz, CDCl3) δ (ppm): 24.73, 40.75, 48.01, 53.55, 55.39, 62.19, 112.34, 117.37, 118.61, 129.46, 136.32,
52.78, 56.91, 126.92, 128.53, 131.54, 134.50, 166.52 and 175.30. HRMS 159.74 and 167.49. HRMS (m/z) calcd for C15H22N2O2 [M + H]+: 263.1760;
(m/z) calcd for C12H15NO3 [M + H]+: 222.1130; Found: 222.1125.
Compound 5c was synthesized according to the procedure described
Found: 263.1711.
N-(1-Ethylpyrrolidin-2-ylmethyl)-4-methoxybenzamide (11c): 1H-NMR
earlier using methyl 2-methyl-2-(methylamino)propanoate as the starting (300 MHz, CDCl3) δ (ppm): 1.12 (3H, t), 1.60–1.77 (3H, m), 1.84–1.93 (1H,
material (55% yield). m), 2.14–2.30 (2H, m), 2.65 (1H, broad m), 2.78–2.89 (1H, m), 3.17–3.31
Methyl 2-methyl-2-(N-methylbenzamido)propanoate (5c): 1H-NMR (2H, m), 3.65–3.73 (1H, m), 3.85 (3H, s), 6.77 (1H, broad s), 6.93 (2H, d)
(300 MHz, CDCl3) δ (ppm): 1.55 (6H, s), 2.97 (3H, s), 3.73 (3H, s) and
and 7.75 (2H, d); 13C-NMR (75 MHz, CDCl3) δ (ppm): 14.10, 22.91, 28.19,
7.38–7.47 (5H, m); 13C-NMR (75 MHz, CDCl3) δ (ppm): 22.95, 33.44, 52.31, 40.67, 47.96, 53.56, 55.34, 62.21, 113.64, 127.14, 128.61, 161.94 and
60.70, 127.28, 128.35, 129.83, 136.44, 171.83 and 174.57. HRMS (m/z) 167.16. HRMS (m/z) calcd for C15H22N2O2 [M + H]+: 263.1760; Found:
calcd for C13H17NO3 [M + H]+: 236.1287; Found: 236.1292.
263.1801.
Copyright © 2013 John Wiley & Sons, Ltd.
J. Label Compd. Radiopharm 2013, 56 672–678